Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A Mastery Approach to Complex Esophageal DiseasesEsophageal Cancer

A Mastery Approach to Complex Esophageal Diseases: Esophageal Cancer [Esophageal cancer is a major global health burden affecting 746,000 individuals and responsible for 459,300 deaths in 2015. Important contributing factors in the development of this disease can include: history of gastrointestinal reflux disease, high rates of visceral obesity, Caucasian race, smoking, and male gender. Symptoms of early esophageal cancer are often vague and non-specific, which makes timely diagnosis even more difficult. Although no routine screening programs currently exist, upper gastrointestinal endoscopy with esophageal biopsy remains the gold standard diagnostic test. Several therapies are available, such as endoscopic therapy, chemotherapy and chemoradiotherapy, and esophagectomy. The overall 5 year survival rate in the United States ranges from 19% to 47%, depending on the staging of the disease.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

A Mastery Approach to Complex Esophageal DiseasesEsophageal Cancer

Editors: Oleynikov, Dmitry; Fisichella, P. Marco

Loading next page...
 
/lp/springer-journals/a-mastery-approach-to-complex-esophageal-diseases-esophageal-cancer-d7BoDAR040
Publisher
Springer International Publishing
Copyright
© Springer International Publishing AG, part of Springer Nature 2018
ISBN
978-3-319-75794-0
Pages
165 –182
DOI
10.1007/978-3-319-75795-7_13
Publisher site
See Chapter on Publisher Site

Abstract

[Esophageal cancer is a major global health burden affecting 746,000 individuals and responsible for 459,300 deaths in 2015. Important contributing factors in the development of this disease can include: history of gastrointestinal reflux disease, high rates of visceral obesity, Caucasian race, smoking, and male gender. Symptoms of early esophageal cancer are often vague and non-specific, which makes timely diagnosis even more difficult. Although no routine screening programs currently exist, upper gastrointestinal endoscopy with esophageal biopsy remains the gold standard diagnostic test. Several therapies are available, such as endoscopic therapy, chemotherapy and chemoradiotherapy, and esophagectomy. The overall 5 year survival rate in the United States ranges from 19% to 47%, depending on the staging of the disease.]

Published: Apr 21, 2018

Keywords: Esophageal cancer; Esophageal adenocarcinoma; Gastroesophageal reflux disease; Barrett’s esophagus; Upper gastrointestinal endoscopy; Esophagectomy

There are no references for this article.